Mr Richard Stanton
Projects as PI
1 of 9
- Analysis of the antiviral efficacy of Nasaleze (01/04/2021 - 30/06/2023)
- Antiviral capacity of surfaces (01/02/2023 - 31/01/2024)
- Bringing together HCMV researchers within the UK (01/11/2016 - 30/04/2017)
- Bringing together human cytomegalovirus researchers within the UK (01/07/2018 - 31/12/2018)
- Developing a novel anti-SARS-CoV-2 Immunotherapy (01/01/2024 - 31/08/2025)
Projects as Co-Investigator
1 of 3
- A randomised controlled trial of the effect of mouthwashes against COVID-19 (08/07/2020 - 15/05/2021)
- A systematic investigation into human cytomegalovirus gene function (08/05/2014 - 31/12/2017)
- Characterisation of a novel class of natural killer cell immunoevasin (01/05/2021 - 28/02/2025)
- Effect of a new glycol-based formulation against bacteria and viruses (19/09/2024 - 31/05/2026)
- Exploring the efficacy and mechanisms of action of a novel formulation (19/11/2022 - 18/05/2023)
